Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Muscle Weakness

3,4-dihydroxyphenylacetic acid has been researched along with Muscle Weakness in 2 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Madiha, S1
Tabassum, S1
Batool, Z1
Liaquat, L1
Sadir, S1
Shahzad, S1
Perveen, T1
Haider, S1
Mohanasundari, M1
Srinivasan, MS1
Sethupathy, S1
Sabesan, M1

Other Studies

2 other studies available for 3,4-dihydroxyphenylacetic acid and Muscle Weakness

ArticleYear
Assessment of gait dynamics in rotenone-induced rat model of Parkinson's disease by footprint method.
    Pakistan journal of pharmaceutical sciences, 2017, Volume: 30, Issue:3(Suppl.)

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Disease Models, Animal;

2017
Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice.
    Journal of the neurological sciences, 2006, Nov-15, Volume: 249, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Ataxia; Bromocriptine; Catalase; Corp

2006